Akums specializes in developing new formulations, undertaking bioequivalence studies, clinical trials, obtaining Drug Controller General of India’s (DCGI) approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Akums’s own technology to its customers under their brand names. Akums manufactures innovative and technology driven products